XML 261 R55.htm IDEA: XBRL DOCUMENT v3.22.4
Share-based compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Payment Schedule of Share-Based Payment Arrangement By Share-Based Payment Award, Performance Criteria
The table below shows the performance criteria and the corresponding weight of the LTI performance plans granted in 2022.
LTI performance plan criteriaMarket/Non-Market elementWeight
Relative TSRMarket30%
Cash Conversion Rate % (3-year average)Non-Market30%
Technology Leadership IndexNon-Market20%
ESG MeasuresNon-Market20%
Total 100%
Schedule of Assumptions Used for Calculation of the Fair Value of Shares
The most important assumptions for the calculation of the fair value of shares for the LTI performance plans, which include a market-based performance criteria, are set out in the following table:
Year ended December 31202020212022
Share price in € at grant date270.7 462.9 548.0 
Expected volatility ASML28.9 %38.5 %41.8 %
Expected volatility PHLX index24.7 %35.3 %n/a
Average volatility of the peer group (market practice)n/an/a47.8 %
Vesting period2.9 years2.9 years2.7 years
Dividend yield0.9 %0.6 %1.0 %
Risk free interest rate (Eurozone)(0.6)%(0.8)%0.5 %
Risk free interest rate (US)1.5 %0.2 %2.8 %
Schedule of Expenses for Share Plans
Expenses for LTI plans, including the Board of Management, were as follows:
Year ended December 31 (€, in millions)202020212022
Total incurred expenses53.9 117.5 68.9 
Recognized income tax benefit (excluding excess income tax benefits)6.6 8.2 10.2 
Total expected expenses in future periods 85.9 125.4 113.0 
Weighted average period in which these expected expenses are to be recognized1.6 years1.7 years1.4 years
Schedule of Shares Activity During Period
Details with respect to shares granted and vested during the year are set out in the following table:
  EUR-denominatedUSD-denominated
Year ended December 31202020212022202020212022
Total fair value at vesting date of shares vested during the year (in millions)124.9 156.9 120.6 133.9 164.0 149.6 
Weighted average fair value of shares granted297.05 547.79 578.65 302.75 498.64 553.61 
A summary of the status of conditionally outstanding shares as of December 31, 2022, and changes during the year ended December 31, 2022, is presented below:
  EUR-denominatedUSD-denominated
 Number
of shares
Weighted
average
fair value at
grant date
Number
of shares
Weighted
average
fair value at
grant date
Conditional shares outstanding at January 1, 2022452,205 303.32 297,001 416.07 
Granted88,432 578.65 230,568 553.61 
Vested(239,685)247.17 (273,861)418.03 
Forfeited(8,187)239.82 (15,314)487.93 
Conditional shares outstanding at December 31, 2022292,765 434.10 238,394 542.22 
Details with respect to stock options exercised and outstanding are set out in the following table:
  EUR-denominatedUSD-denominated
Year ended December 31202020212022202020212022
Weighted average share price at the exercise date of stock options302.20 583.33 494.14 355.44 658.16 565.39 
Aggregate intrinsic value of stock options exercised (in millions)4.8 5.7 4.4 3.7 4.1 1.6 
Weighted average remaining contractual term of currently exercisable options (in years)3.552.812.083.662.932.09
Aggregate intrinsic value of exercisable stock options (in millions)22.4 36.7 20.3 16.9 24.9 14.6 
Aggregate intrinsic value of outstanding stock options (in millions)22.4 36.7 20.3 16.9 24.9 14.6 
Schedule of Number and Weighted Average Exercise Prices of Stock Options Activity
The number and weighted average exercise prices of stock options as of December 31, 2022, and changes during the year then ended are presented below:
   EUR-denominatedUSD-denominated
 Number
of options
Weighted
average
exercise price
per ordinary
share (EUR)
Number
of options
Weighted
average
exercise price
per ordinary
share (USD)
Outstanding, January 1, 202257,923 73.87 35,251 90.36 
Granted 1
    
Exercised(10,016)55.49 (3,113)64.73 
Forfeited    
Expired(300)40.03   
Outstanding, December 31, 202247,607 77.95 32,138 92.84 
Exercisable, December 31, 202247,607 77.95 32,138 92.84 
1.As of 2017, we no longer grant options to our employees.
Schedule of Range of Exercise Prices, Number of Outstanding Options, and Weighted Average Remaining Contractual Life of Oustanding Options
Details with respect to stock options exercised in the relevant year and outstanding stock options as of December 31, 2022, are set out in the following table:
EUR-denominatedUSD-denominated
Range of exercise prices (€)
Number of outstanding optionsWeighted average remaining contractual life of outstanding (years)Range of exercise prices (USD)Number of outstanding optionsWeighted average remaining contractual life of outstanding (years)
50–60
5,268 0.96
50–60
— 0.00
60–70
10,773 0.96
60–70
278 0.06
70–80
10,109 2.35
70–80
828 0.30
80–90
10,791 2.83
80–90
8,855 1.90
90–100
10,666 2.73
90–100
15,308 2.05
100–110
— 0.00
100–110
6,869 2.74
Total47,607 2.08Total32,138 2.09